Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Targeting innate immunity to treat long-term type 1 diabetes.

King CC.

Regen Med. 2012 Nov;7(6):753-4. No abstract available.

PMID:
23304723
2.

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.

Pickup JC.

Diabetes Care. 2004 Mar;27(3):813-23. Review.

PMID:
14988310
3.

Is type II diabetes mellitus a disease of the innate immune system?

Pickup JC, Crook MA.

Diabetologia. 1998 Oct;41(10):1241-8. Review.

PMID:
9794114
4.

Complexities of targeting innate immunity to treat infection.

Brown KL, Cosseau C, Gardy JL, Hancock RE.

Trends Immunol. 2007 Jun;28(6):260-6. Epub 2007 Apr 30. Review.

PMID:
17468048
5.

Innate immunity and its role in type 1 diabetes.

Zipris D.

Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):326-31. doi: 10.1097/MED.0b013e3283073a46. Review.

PMID:
18594272
6.

Innate immunity in type 1 diabetes.

Zipris D.

Diabetes Metab Res Rev. 2011 Nov;27(8):824-9. doi: 10.1002/dmrr.1256.

PMID:
22069267
7.

A role for innate immunity in type 1 diabetes?

Beyan H, Buckley LR, Yousaf N, Londei M, Leslie RD.

Diabetes Metab Res Rev. 2003 Mar-Apr;19(2):89-100. Review.

PMID:
12673777
8.
9.

Innate immunity, insulin resistance and type 2 diabetes.

Fernández-Real JM, Pickup JC.

Trends Endocrinol Metab. 2008 Jan;19(1):10-6. Epub 2007 Dec 21. Review.

PMID:
18082417
10.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

11.

Intensive therapy for diabetes through influence on innate immune system.

Li ZZ, Liu JB, Li L, Jiao L, Chen L.

Med Hypotheses. 2009 Jun;72(6):675-6. doi: 10.1016/j.mehy.2009.01.028. Epub 2009 Mar 4.

PMID:
19264419
12.

The soluble pattern recognition receptor pentraxin-3 in innate immunity, inflammation and fertility.

Garlanda C, Maina V, Cotena A, Moalli F.

J Reprod Immunol. 2009 Dec;83(1-2):128-33. doi: 10.1016/j.jri.2009.05.006. Epub 2009 Nov 8. Review.

PMID:
19900712
13.

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.

Kanzler H, Barrat FJ, Hessel EM, Coffman RL.

Nat Med. 2007 May;13(5):552-9. Review.

PMID:
17479101
14.

CpG oligodeoxynucleotide stimulates protective innate immunity against human renal cell carcinoma xenografted in nude mice.

Zhou PJ, Ma BB, He W, Xu D, Wang XH.

J Immunother. 2011 Sep;34(7):535-41. doi: 10.1097/CJI.0b013e3182272ecf.

PMID:
21760530
15.

Orchestrating innate immune responses in multiple sclerosis: molecular players.

Fernández M, Montalban X, Comabella M.

J Neuroimmunol. 2010 Aug 25;225(1-2):5-12. doi: 10.1016/j.jneuroim.2010.05.014.

PMID:
20537409
16.

Targeting the innate immune system in pediatric inflammatory bowel disease.

Schirbel A, Fiocchi C.

Expert Rev Gastroenterol Hepatol. 2011 Feb;5(1):33-41. doi: 10.1586/egh.10.76.

PMID:
21309670
17.

Innate immunity influences long-term outcomes after human lung transplant.

Palmer SM, Burch LH, Trindade AJ, Davis RD, Herczyk WF, Reinsmoen NL, Schwartz DA.

Am J Respir Crit Care Med. 2005 Apr 1;171(7):780-5. Epub 2005 Jan 7.

PMID:
15640363
18.
19.

[Cells of innate and adaptive immunity in type 2 diabetes and obesity].

Guzmán-Flores JM, López-Briones S.

Gac Med Mex. 2012 Jul-Aug;148(4):381-9. Review. Spanish.

20.

Role of eosinophils and neutrophils in innate and adaptive protective immunity to larval strongyloides stercoralis in mice.

Galioto AM, Hess JA, Nolan TJ, Schad GA, Lee JJ, Abraham D.

Infect Immun. 2006 Oct;74(10):5730-8.

Supplemental Content

Support Center